Dx Deals: Labcorp Acquires Stake in European Testing Giant
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
From - Laboratory Industry Report
Here's a summary of the key product launches from late May through the third week of…
From - Laboratory Industry Report
The diagnostics industry got off to a so-so start with PAMA reimbursement cuts, a weak flu season relative to…
By Leora Borgenicht bio
Before the healthcare industry can ambitiously transform to offer more accurate and personalized patient care, certain stepping stones must…
From - Laboratory Industry Report
The FDA broke new ground by clearing a pair of STD screening assays for detecting chlamydia and gonorrhea for use with extragenital specimens, specifically from the…
From - Laboratory Industry Report
Here's a summary of the key product launches from late April to late May, 2019…
From - Laboratory Industry Report
Although there's no single formula for marketing a lab, there are five basic elements a marketing plan should include&…
From - Laboratory Industry Report
The pace of diagnostic deal making picked up from the end of March through mid-April. Here's a quick overview of the activity and…
From - Laboratory Industry Report
Qiagen was the most active firm of the period with a trio of new product launches, including the US launch of…